CS logo
small CS logo
Universitat Leipzig Medizinische Fakultat

Leipzig, Germany

About Universitat Leipzig Medizinische Fakultat


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Universitat Leipzig Medizinische Fakultat


During the past decade, Universitat Leipzig Medizinische Fakultat conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Universitat Leipzig Medizinische Fakultat" #1 collaborator was "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "ClinIntel" with 1 trials as a collaborator, "Clinical Reference Laboratory" with 1 trials as a collaborator, "DSG EDC" with 1 trials as a collaborator and "Diamond Pharma Services Regulatory Affairs Consultancy" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

Clinical Trials Conditions at Universitat Leipzig Medizinische Fakultat


According to Clinical.Site data, the most researched conditions in "Universitat Leipzig Medizinische Fakultat" are "Acute Myeloid Leukemia" (1 trials), "Fatty Liver" (1 trials), "Liver Diseases" (1 trials), "Liver Fibroses" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Universitat Leipzig Medizinische Fakultat" in a lesser frequency.

Clinical Trials Intervention Types at Universitat Leipzig Medizinische Fakultat


Most popular intervention types in "Universitat Leipzig Medizinische Fakultat" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Aramchol" (1 trials), "Imetelstat" (1 trials), "Other Biologic Agents" (1 trials) and "Vedolizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Universitat Leipzig Medizinische Fakultat


The vast majority of trials in "Universitat Leipzig Medizinische Fakultat" are 3 trials for "All" genders.

Clinical Trials Status at Universitat Leipzig Medizinische Fakultat


Currently, there are NaN active trials in "Universitat Leipzig Medizinische Fakultat". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Universitat Leipzig Medizinische Fakultat, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Universitat Leipzig Medizinische Fakultat, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".